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Clinical research, especially clinical trials, often have 
a large proportion of missing data. One of the problems 
frequently observed is that patients have non-compliance 
with the treatment protocol, i.e. they do not follow the 
instructions of the researcher/clinician. This fact gene-
rates problems with the statistical analysis because they 
can bias the outcomes of the research.1
In many clinical trials, probably most of them, missing 
data is almost inevitable. In recent years this problem 
has been intensively discussed in the scientific literature, 
showing the complexity and difficulties to complete the 
statistical analysis when data are incomplete. 
A group of international experts established a set of 
general principles included in methodological guidelines 
to ensure the quality of results of clinical trials. In ge-
neral, all guidelines/principles focus on designing strate-
gies in order to minimize possible missing data. Another 
strategy is to enhance the statistical analysis through the 
use of all the information obtained from the subjects, i.e. 
other variables with no missing data, or using sensitivity 
analysis.1
Missing data is more common than we think. Seve-
ral authors have identified a rate ranging from 15% to 
20% in educational research, and from 36% to 48% 
in psychological research.2,3 Statistical literature shows 
an extensive description and application of methods to 
handle missing data.
Some researchers address this problem excluding 
patients who did not comply with the protocol. This 
method called per-protocol-analysis corresponds to the 
statistical analysis of the patients who received randomi-
zed assigned intervention.
The intention-to-treat (ITT) analysis is another 
methodological strategy to handle missing data, mainly in 
clinical trials. This methodology considers the analysis of 
all individuals enrolled in the trial, according to their allo-
cation, even if they have not complied with the assigned 
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protocol. ITT analysis has two basic rules: analyze accor-
ding to original allocation and include all randomized 
subjects in the analysis. Both rules generally try to pre-
vent selection and drop-out bias.4 Thus, the goal to ba-
lance known and unknown prognostic factors through 
the randomization is accomplished.
The ITT analysis has many advantages, especially to 
reveal the actual clinical setting, because it considers 
that some patients may not comply with the protocol 
established in the clinical trial, giving an unbiased esti-
mate of the treatment effect. The bias would occur if the 
non-compliance or drop-out subjects were eliminated 
from the final analysis, because this could create larger 
differences in the outcome of each group. Another ad-
vantage is that ITT analysis preserves the original sam-
ple size, so the type I error is minimized, allowing a 
greater generalization of the results.
However, the ITT analysis has disadvantages such as 
the underestimation of the magnitude of the effect. This 
underestimation is caused by the subjects who do not 
comply with the protocol. In the case of studies assessing 
adverse effects, the ITT analysis may not be the most 
appropriate.
Missing data in the ITT also corresponds to the re-
moval of patients due to adverse effects related to in-
terventions tested in the clinical studies. These data 
can be classified as missing data completely at random 
(MCAR), missing at random data (MAR) or missing 
data not at random (MNAR) data. The latter type of 
data occurs when the missing data depends on unobser-
ved values, so it can cause a bias in the study outcomes.
The problem generated by missing data in completely 
randomized clinical trials can be addressed by imputing 
data through statistical estimations. The two imputation 
methods commonly used are last observation carried 
forward (LOCF) or baseline observation carried forward 
(BOCF). LOCF uses the last observed value in place of 
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the missing outcome, whereas BOCF uses the baseline 
value to replace the missing value. Both methods have 
been widely criticized because they introduce a bias. A 
newer method is multiple imputations. This involves the 
estimation of plausible values based on a Bayesian ap-
proach4 in order to replace the missing values.
Despite the fact that there are many methods and ap-
proaches to manage missing data, the first recommen-
dation is to prevent missing data. Therefore, in clini-
cal research the variables of interest should be planned 
before the study and rigorously measured over the data 
collection.
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